1. Stocks
  2. Vivanza Biosciences Ltd.
  3. Swot
swot-logo

Vivanza Biosciences Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Vivanza Biosciences Ltd. has 5 Strengths, 19 Weaknesses, 0 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

PEG lower than Industry PEG

Companies with Zero Promoter Pledge

Stock with Low PE (PE < = 10)

Top Gainers

Rising Delivery Percentage Compared to Previous Day and Month, Strong Volumes

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Lowest Momentum Scores (Technical Scores)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Inefficient use of capital to generate profits - RoCE declining in the last 2 years

Inefficient use of shareholder funds - ROE declining in the last 2 years

Degrowth in Revenue and Profit

Declining Revenue every quarter for the past 2 quarters

Low Piotroski Score : Companies with weak financials

Declining Net Cash Flow : Companies not able to generate net cash

Annual net profit declining for last 2 years

Major fall in TTM Net Profit

Fall in Quarterly Revenue and Net Profit (YoY)

Weak performer : Stock lost more than 20% in 1 month

Weak Momentum: Price below Short, Medium and Long Term Averages

Profit to Loss Companies

Degrowth in Revenue, Profits and Operating Profit Margin in recent results (QoQ)

Increasing Trend in Non-Core Income

RSI indicating price weakness

Highest fall from 52 Week High

Big Deal (Insider and SAST) sells last month greater than 1% of total shares

Insiders sold stocks

High Delivery Percentage

Decline in Net Profit with falling Profit Margin (QoQ)

Decline in Quarterly Net Profit with falling Profit Margin (YoY)